Direkt zum Inhalt

Owner only: item control page
Fiegl, M ; Unterhalt, M ; Kern, W ; Braess, J ; Spiekermann, K ; Staib, P ; Grüneisen, A ; Wörmann, B ; Schöndube, D ; Serve, H ; Reichle, A ; Hentrich, M ; Schiel, X ; Sauerland, C ; Heinecke, A ; Rieger, C ; Beelen, D ; Berdel, W E ; Büchner, T ; Hiddemann, W

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Fiegl, M, Unterhalt, M, Kern, W, Braess, J, Spiekermann, K, Staib, P, Grüneisen, A, Wörmann, B, Schöndube, D, Serve, H , Reichle, A, Hentrich, M, Schiel, X, Sauerland, C, Heinecke, A, Rieger, C, Beelen, D, Berdel, W E, Büchner, T and Hiddemann, W (2014) Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG. Leukemia 28 (5), pp. 1001-1007.

Date of publication of this fulltext: 19 Dec 2024 08:10
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleLeukemia
Publisher:NATURE PUBLISHING GROUP
Place of Publication:LONDON
Volume:28
Number of Issue or Book Chapter:5
Page Range:pp. 1001-1007
Date2014
InstitutionsMedicine > Lehrstuhl für Innere Medizin II
Identification Number
ValueType
10.1038/leu.2013.297DOI
KeywordsACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; CYTOSINE-ARABINOSIDE; FLAG-IDA; G-CSF; PHASE-III; ARA-C; IDARUBICIN; CHEMOTHERAPY; THERAPY; acute myeloid leukemia; relapse; chemotherapy; cytarabine; fludarabine
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID61507

Export bibliographical data

Owner only: item control page

nach oben